Not applicableAvailableNCT03539380What this trial is testingTRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease TauRx Therapeutics Ltd
Testing effectiveness (Phase 2)Study completedNCT04251182What this trial is testingClinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD SubjectsWho this might be right forAlzheimer Disease T3D Therapeutics, Inc. 250
Testing effectiveness (Phase 2)Study completedNCT03001557What this trial is testingStudy of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease DementiaWho this might be right forIrregular Sleep-Wake Rhythm Disorder Eisai Inc. 63
Post-approval studies (Phase 4)Ended earlyNCT01181921What this trial is testingThe CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Janssen-Cilag, S.A. 1
Not applicableEnded earlyNCT02249468What this trial is testingAn Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian PopulationWho this might be right forMild and Moderate Alzheimer's DiseaseCognitively Healthy People Danone Nutricia Research 191
Large-scale testing (Phase 3)Study completedNCT00838110What this trial is testingEvaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 742
Not applicableStudy completedNCT06151808What this trial is testingAnalysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD SubjectsWho this might be right forAlzheimer Disease Sinotau Pharmaceutical Group 42
Early research (Phase 1)Study completedNCT00965588What this trial is testingStudy to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease United Biomedical 19
Not applicableEnded earlyNCT03672474What this trial is testingREGEnLIFE RGn530 - Feasibility PilotWho this might be right forAlzheimer Disease University Hospital, Montpellier 60
Early research (Phase 1)Study completedNCT04040348What this trial is testingAlzheimer's Disease Stem Cells Multiple InfusionsWho this might be right forAlzheimer Disease Bernard (Barry) Baumel 6
Large-scale testing (Phase 3)Looking for participantsNCT06534723What this trial is testingPhase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)Who this might be right forAlzheimer's Dementia Sichuan Jishengtang Pharmaceutical Co., Ltd. 570
Testing effectiveness (Phase 2)Study completedNCT05189210What this trial is testingGV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)Who this might be right forMild to Moderate Alzheimer's Disease GemVax & Kael 199
Early research (Phase 1)Study completedNCT01369225What this trial is testingOpen Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 52
Not applicableUnknownNCT05114499What this trial is testingEfficacy and Safety of Donepezil and Sodium Oligomannate in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease First Affiliated Hospital Xi'an Jiaotong University 150
Early research (Phase 1)Study completedNCT03635047What this trial is testingA Phase I Study for Safety and Tolerability of AL002.Who this might be right forHealthyAlzheimer Disease Alector Inc. 69
Testing effectiveness (Phase 2)Study completedNCT01549834What this trial is testingEvaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsWho this might be right forAlzheimer's Disease AbbVie (prior sponsor, Abbott) 434
Not applicableStudy completedNCT03349320What this trial is testingResponse to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic PolymorphismsWho this might be right forLate Onset Alzheimer Disease Federal University of Minas Gerais 37
Testing effectiveness (Phase 2)Study completedNCT02359552What this trial is testingRasagiline Rescue in Alzheimer's Disease Clinical TrialWho this might be right forAlzheimer's Disease The Cleveland Clinic 50
Very early researchStudy completedNCT06489015What this trial is testingRecombinant Human Serum Albumin in the Treatment of Mild-to-moderate AD (Alzheimer's Disease) Exploratory Clinical TrialWho this might be right forAlzheimer's Disease (AD) Shenzhen Protgen Co., Ltd. 30
Not applicableUnknownNCT03773016What this trial is testingTouchscreen Technology and Art for People With Dementia in Care HomesWho this might be right forMild DementiaModerate Dementia University of Nottingham 12